CD59's Role in DLBCL Treatment Outcomes

Created using ChatSlide

This presentation explores the role of CD59 in diffuse large B-cell lymphoma (DLBCL), detailing the study's background, experimental design, and key findings. It highlights how CD59 silencing affects cell viability, apoptosis, and treatment response, particularly in relation to doxorubicin. The prognostic implications of CD59 expression are discussed, emphasizing its potential to predict treatment outcomes and guide therapeutic strategies, while noting that it may not serve as a universal...